By: P.T., STA
The pharmaceutical group Krka generated EUR 1.53 billion in revenue last year, up 3% compared to 2019, with net profit estimated at a record EUR 286.6 million, up 17% year-on-year, show the unaudited preliminary results.
CEO Jože Colarič noted that even though the pandemic had hindered marketing-and-sales activities, the Krka group recorded “best sales results ever”. Product and service sales were up in all regions except Slovenia (-8%) and the overseas markets (-6%).
